Domestic Violence: 25 percent of women surveyed by the government say they were violently attacked by their husbands or boyfriends in a finding one federal official called “astounding,” the Associated Press reports.
C-Sections: The number of births by Cesarean section in Calif. has risen 50 percent in the past 10 years, new research shows, but it isn’t because of the health benefits over vaginal delivery. Researchers cite financial incentives for doctors and an “awareness gap” of the procedure’s risks among the explanations, Stephanie O’Neill reports for KPCC public radio.
Health Reform: South Carolina Gov. Nikki Haley predetermined the findings of a state committee working on health reform even before Read more »
*This blog post was originally published at Reporting on Health - The Reporting on Health Daily Briefing*
In 2007, when the results were published from the COURAGE trial, all the experts agreed that this study would fundamentally change the way cardiologists managed patients with stable coronary artery disease (CAD).*
*”Stable” CAD simply means that a patient with CAD is not suffering from one of the acute coronary syndromes – ACS, an acute heart attack or unstable angina. At any given time, the large majority of patients with CAD are in a stable condition.
But a new study tells us that hasn’t happened. The COURAGE trial has barely budged the way cardiologists treat patients with stable CAD.
Lots of people want to know why. As usual, DrRich is here to help.
The COURAGE trial compared the use of stents vs. drug therapy in patients with stable CAD. Over twenty-two hundred patients were randomized to receive either optimal drug therapy, or optimal drug therapy plus the insertion of stents. Patients were then followed for up to 7 years. Much to the surprise (and consternation) of the world’s cardiologists, there was no significant difference in the incidence of subsequent heart attack or death between the two groups. The addition of stents to optimal drug therapy made no difference in outcomes.
This, decidedly, was a result which was at variance with the Standard Operating Procedure of your average American cardiologist, whose scholarly analysis of the proper treatment of CAD has always distilled down to: “Blockage? Stent!”
But after spending some time trying unsuccessfully to explain away these results, even cardiologists finally had to admit that the COURAGE trial was legitimate, and that it was a game changer. (And to drive the point home, the results of COURAGE have since been reproduced in the BARI-2D trial.) Like it or not, drug therapy ought to be the default treatment for patients with stable CAD, and stents should be used only when drug therapy fails to adequately control symptoms.
When the COURAGE results were initially published they made a huge splash among not only cardiologists, but also the public in general. So cardiologists did not have the luxury of hiding behind (as doctors so often do when a study comes out the “wrong” way) the usual, relative obscurity of most clinical trials. Given the widespread publicity the study generated, it seemed inconceivable that the cardiology community could ignore these results and get away with it.
But a new study, published just last month in JAMA, reveals that ignore COURAGE they have. Read more »
*This blog post was originally published at The Covert Rationing Blog*
You can be for freedom. You can be for smaller government that intrudes less. You can be for lower taxes. You can be for most anything, but if you’re interested in improving the sagging health of American citizens, get on Michael Bloomberg’s wheel.
As reported in the Wall Street Journal, NYC mayor, Michael Bloomberg, has asked the U.S. Department of Agriculture to bar city residents from using food stamps to buy sugary soft drinks. It turns out that last year $135 million in food stamp money was used for the consumption of these obesity-fostering beverages in NYC alone.
Mr Bloomberg is morphing into a real-world public health super star. Previously, he was a pioneer in banning smoking in restaurants and bars. They said it could not be done, or that it wouldn’t work. Well, the naysayers were dead wrong. Now public smoking bans our commonplace and, backed by objective data, are accepted as having prevented thousands of heart attacks. Read more »
*This blog post was originally published at Dr John M*
Heart attack mortality fell by nearly a half a percent last year at 4,500 hospitals that treat Medicare patients. And, facilities with the lowest and highest death rates saw similar declines, according to a new hospital report card by the U.S. Centers for Medicare and Medicaid Services (CMS).
Heart attack mortality fell from a national average of 16.6 percent last year to 16.2 percent, with a range among all facilities from 14.5 percent to 17.9 percent. CMS released the data as part of its hospital report card effort to spur better quality and outcomes through public reporting of recommended treatments. The agency added heart attack and heart failure mortality to the report card three years ago.
At issue now is what’s driving the figures: public reporting of hospital data driving improvement, or faster door-to-balloon-treatment times. Areas that do need to improve include lowering readmissions and getting people to the hospital faster when they have a heart attack. (USA Today)
*This blog post was originally published at ACP Hospitalist*